Applied Clinical Trials
Study shows sharp reduction in market exclusivity periods for first-in-class treatment entrants.
Tufts, CSDD
Advertisement
Articles by Tufts, CSDD
Applied Clinical Trials
Study finds that almost 75% of cancer drug candidates rely on biomarker data.
Applied Clinical Trials
Tufts CSDD
Advertisement
Latest Updated Articles
Survey Results of Start-Up Cycle TimesNovember 1st 2012
Oncology Leads Personalized MedicineJune 1st 2015
Competitive Pressure for First-in-Class Drugs is IntensifyingFebruary 1st 2016
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
2
Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First
3
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
4
Why Time Savings Is the Largest Driver of RBQM's Financial Value
5